Federated Hermes’s Co-Diagnostics CODX Stock Holding History

Federated Hermes’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-91	Closed	-$3.03K	–	2120
2023 Q2	$3.03K	Buy	+91	New	+$3.48K	﹤0.01%	1958
2022 Q3	–	Sell	-1,631	Closed	-$275K	–	2153
2022 Q2	$275K	Sell	1,631 -25	-2%	-$3.8K	﹤0.01%	1487
2022 Q1	$307K	Sell	1,656 -50	-3%	-$10.4K	﹤0.01%	1538
2021 Q4	$457K	Sell	1,706 -654	-28%	-$172K	﹤0.01%	1501
2021 Q3	$689K	Sell	2,360 -396	-14%	-$116K	﹤0.01%	1414
2021 Q2	$682K	Buy	+2,756	New	+$708K	﹤0.01%	1436
2021 Q1	–	Sell	-51	Closed	-$14K	–	2244
2020 Q4	$14K	Buy	51 +13	+34%	+$4.82K	﹤0.01%	1936
2020 Q3	$15K	Buy	+38	New	+$19.5K	﹤0.01%	1925

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Federated Hermes's CODX Position: Q3 2023 in Review

Federated Hermes sold out of Co-Diagnostics (CODX) in Q3 2023, closing a stake of 91 shares — an estimated $3.03K sold.

Federated Hermes first reported a position in CODX in Q3 2020 and held it in 8 quarters. The position peaked at $689K in Q3 2021. 43 funds tracked by Wall St. Rank hold CODX as of Q3 2023.

Federated Hermes reported no remaining Co-Diagnostics position as of Q3 2023 after selling out during the quarter.
Federated Hermes sold 91 Co-Diagnostics shares in Q3 2023, an estimated $3.03K.
Federated Hermes first reported a position in Co-Diagnostics in Q3 2020 and held it in 8 quarters.
Federated Hermes's Co-Diagnostics position peaked at $689K in Q3 2021.
43 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.